21 Apr 2026 bundleStory 3 of 43

SCIENCEHIGH PRIORITYUPSC · HighSSC · HighBanking · LowRailway · LowDefence · Low

Tanzania field study confirms genetically modified mosquitoes can block malaria parasites in real-world human infections.

तंज़ानिया में किए गए क्षेत्र-अध्ययन ने पुष्टि की — आनुवंशिक रूप से संशोधित मच्छर वास्तविक मानव संक्रमणों में मलेरिया परजीवी को रोक सकते हैं।

21 April 2026·Published research on GM mosquito field trials in Tanzania

Why in News

A landmark field study conducted in Tanzania has confirmed for the first time that CRISPR-Cas9-engineered mosquitoes can block transmission of wild malaria parasites — not just weakened laboratory strains — in real-world human infections. The finding advances the gene-drive approach against a disease that kills over 600,000 people annually worldwide, mostly African children, and where insecticides and anti-malarial drugs face mounting resistance.

At a Glance

Study location: Tanzania (East Africa) — field conditions with wild malaria parasites and local children
Core technology: CRISPR-Cas9 gene editing + gene drive inheritance mechanism
Gene-drive inheritance rate: over 90% of offspring carry the modified gene (vs 50% under standard Mendelian inheritance)
Parasite targeted: Plasmodium species (malaria-causing)
Target mosquito species: Anopheles gambiae — primary malaria vector in Africa
Two modification strategies: Population modification (block parasite transmission) and population suppression (reduce mosquito numbers via sterility genes)
Safety design: Split gene drives (components in separate mosquito lines) used for phased testing before self-propagating release

Key Fact

A Tanzania field study has confirmed that genetically modified mosquitoes — engineered using CRISPR-Cas9 to carry gene drives — can effectively block malaria parasite transmission in real-world infections, not just in laboratory settings. Gene drives ensure that the modified gene passes to over 90% of offspring (versus the standard 50% under Mendelian inheritance), allowing a trait to spread through an entire wild population in a few generations. Two strategies are used: population modification (adding genes that produce antimicrobial peptides in the mosquito's midgut to destroy Plasmodium parasites after a blood meal) and population suppression (targeting sterility genes such as doublesex to collapse female populations). Testing is phased via split gene drives, with safety and efficacy evaluated before any self-propagating release.

तंज़ानिया में किए गए क्षेत्र-अध्ययन ने पुष्टि की है कि CRISPR-Cas9 द्वारा संशोधित मच्छर — जिनमें 'जीन ड्राइव' डाला गया है — वास्तविक संक्रमणों में मलेरिया परजीवी के संचरण को प्रभावी रूप से रोक सकते हैं। जीन ड्राइव के कारण संशोधित जीन 90% से अधिक संतानों में पहुँचता है (परंपरागत मेंडेलीय वंशागति में केवल 50%)। दो रणनीतियाँ उपयोग में हैं: जनसंख्या संशोधन (एंटी-परजीवी अणु उत्पन्न करना) तथा जनसंख्या दमन (बाँझपन जीन के माध्यम से)।

Mendelian vs gene-drive inheritance

मेंडेलीय बनाम जीन ड्राइव वंशागति

Aspect पहलू	Standard (Mendelian) मानक (मेंडेलीय)	Gene drive जीन ड्राइव
Inheritance rate वंशागति दर	Approximately 50% लगभग 50%	Over 90% 90% से अधिक
Population spread speed जनसंख्या में प्रसार गति	Many generations कई पीढ़ियाँ	Few generations कुछ पीढ़ियाँ
Reversibility प्रतिवर्तीयता	Easily fades आसानी से समाप्त	Persists while species exists प्रजाति के साथ बना रहता है
Typical use सामान्य उपयोग	Traditional breeding पारंपरिक प्रजनन	Vector control, conservation वेक्टर नियंत्रण, संरक्षण

How GM mosquitoes block malaria

GM मच्छर मलेरिया को कैसे रोकते हैं

Step 1
CRISPR-Cas9 edit
CRISPR-Cas9 संपादन
Insert anti-parasite genes· एंटी-परजीवी जीन डालें
Step 2
Gene drive
जीन ड्राइव
90%+ inheritance· 90%+ वंशागति
Step 3
Midgut activation
मिडगट सक्रियण
Triggered by blood meal· रक्त भोजन द्वारा प्रारंभ
Step 4
Parasite blocked
परजीवी अवरुद्ध
No malaria transmission· मलेरिया संचरण नहीं

Static GK

•CRISPR-Cas9: Genome-editing tool derived from bacterial adaptive immunity; Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer Doudna
•Gene drive: A genetic system that biases inheritance to ensure a trait spreads through a population at near-100% rates, bypassing normal 50% Mendelian inheritance
•Mendelian inheritance: Standard rules of genetic inheritance from Gregor Mendel; each parent contributes one allele, with roughly 50% transmission probability for heterozygous traits
•Plasmodium: Genus of parasitic protozoa causing malaria; major species include P. falciparum (most lethal), P. vivax, P. malariae, P. ovale, P. knowlesi
•Anopheles gambiae: Principal malaria vector in Africa; target species for most African gene-drive research
•Split gene drives: Safety design where drive components are maintained in separate mosquito lines, requiring both to mate for full drive action — limits spread during testing

Mnemonic · Memory Hooks

→CRISPR-Cas9 = molecular scissors. Nobel 2020 — Charpentier + Doudna. Do scientists, dono mahilayen.
→Gene drive = 90%+ inheritance (vs Mendelian 50%). 'Traditional genetics ko bypass karta hai'.
→Do strategies: Population modification (parasite block) vs Population suppression (sterility genes).
→Target mosquito: Anopheles gambiae (Africa ka main malaria vector). Target parasite: Plasmodium.
→Tanzania field study = pehla real-world wild-parasite proof. Lab nahi, ground level.
→Split gene drive = safety design — two separate lines mein components, dono saath aayenge tab hi drive activate hoga.
→Sterility gene example: 'doublesex' — female sterility inducing.

Exam Angles

SSC / Railway

A Tanzania field study has confirmed that CRISPR-Cas9-engineered mosquitoes carrying gene drives can block malaria transmission in real-world human infections; gene drives pass the modified gene to over 90% of offspring versus standard 50% Mendelian inheritance.

Practice (4)

Q1. The CRISPR-Cas9 system — used in the GM mosquito technology — won the Nobel Prize in Chemistry in 2020. It was awarded to:

A.James Watson and Francis Crick
B.Emmanuelle Charpentier and Jennifer Doudna
C.Barbara McClintock and George Beadle
D.Paul Berg and Walter Gilbert

tap to reveal answer

Answer: B. Emmanuelle Charpentier and Jennifer Doudna

The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for the CRISPR-Cas9 genome-editing method.

Q2. A gene drive mechanism, as used in GM mosquitoes, ensures that the modified gene passes to what percentage of offspring?

A.Exactly 25%
B.Approximately 50% (standard Mendelian)
C.Over 90%
D.100%, always

tap to reveal answer

Answer: C. Over 90%

Gene drives bias inheritance so the modified gene passes to over 90% of offspring, compared with the standard ~50% under Mendelian inheritance.

Q3. The primary malaria-causing parasite genus is:

A.Plasmodium
B.Trypanosoma
C.Leishmania
D.Wuchereria

tap to reveal answer

Answer: A. Plasmodium

Plasmodium is the genus of parasitic protozoa that cause malaria; the most lethal species is P. falciparum.

Q4. Which mosquito species is the principal malaria vector in Africa and is therefore the primary target for most gene-drive research?

A.Aedes aegypti
B.Culex pipiens
C.Anopheles gambiae
D.Anopheles stephensi

tap to reveal answer

Answer: C. Anopheles gambiae

Anopheles gambiae is the principal malaria vector in Africa. (Aedes aegypti is the primary vector for dengue and yellow fever; Anopheles stephensi is more prominent in urban Asian contexts.)

UPSC Mains

GS-III: Science and Technology — developments and their applications and effects in everyday lifeGS-III: Biotechnology — issues relating to intellectual property rightsGS-II: Issues relating to health

Gene-drive technology, enabled by CRISPR-Cas9, represents a paradigm shift from traditional vector-control approaches (insecticides, bed nets, anti-malarials) to genetic modification of the vector itself. Malaria kills over 600,000 people globally each year, mostly African children; resistance to traditional interventions has been accelerating. The Tanzania field study represents a methodological milestone — demonstrating that GM mosquitoes work against wild parasite strains in real-world conditions, a critical validation before any scale deployment. However, gene drives are ecologically unprecedented: once released, a self-propagating drive persists in the environment as long as the target population exists. This raises governance, ethics, and ecological questions that regulatory frameworks are still catching up with.

Dimensions

ScientificGene drives bypass Mendelian inheritance; population-scale effects achievable within generations — a fundamentally new intervention tier.
Public-healthPotential to reach remote populations where traditional healthcare infrastructure fails; aligns with WHO's malaria elimination targets.
EcologicalTarget-species collapse or modification has cascade effects on food webs; Anopheles gambiae is prey for multiple species.
Ethical / governanceCross-border mobility of mosquitoes means effects cannot be contained within release country; raises sovereignty, consent, and liability questions.
EquityDeveloping the technology in Tanzania (African leadership) addresses historical asymmetries where African populations bear disease burden while Western labs develop interventions.

Challenges

Regulatory frameworks for gene-drive organisms are underdeveloped globally; Cartagena Protocol covers GMOs but gene drives raise novel issues.
Irreversibility risk — a self-propagating drive cannot be easily recalled once released.
Cross-border effects — mosquitoes migrate; affected countries may not have consented.
Ecological cascade — impact on predator species, other non-target organisms.
Evolutionary response — parasites or mosquitoes may evolve resistance to the drive.

Way Forward

Phased deployment via split gene drives (already implemented) that limit population-scale spread during testing.
Multi-country governance frameworks under WHO auspices for cross-border release coordination.
Robust post-release monitoring for ecological and evolutionary effects.
Mandatory community consent processes in affected regions, not just host country consent.
Investment in African scientific capacity so that the technology's governance reflects the burden geography.

Mains Q · 250w

The Tanzania gene-drive mosquito study represents a scientific breakthrough but raises unprecedented governance questions. Discuss the opportunities and regulatory challenges of gene-drive technology in public health. (250 words)

Intro: The Tanzania field confirmation that CRISPR-Cas9-engineered mosquitoes can block malaria transmission in wild parasites — combined with gene-drive inheritance biased above 90% — marks a scientific breakthrough with public-health and governance implications at a scale the regulatory system has not previously faced.

Scientific novelty: gene drives bypass Mendelian inheritance; population-scale change within generations.
Public-health opportunity: potential reach to remote populations where traditional healthcare fails; aligns with WHO elimination targets.
Ecological risk: target collapse affects predator species; cascade effects on food webs.
Governance gap: Cartagena Protocol covers GMOs but gene drives raise cross-border, irreversibility, and consent questions.
Evolutionary risk: drives may be evaded by parasite or mosquito evolution.
Framework: phased split-drive deployment, multi-country WHO-convened governance, mandatory community consent, post-release monitoring, African scientific capacity investment.

Conclusion: Gene-drive technology is a genuine public-health breakthrough and a genuine governance problem. The regulatory architecture must catch up with the science — cross-border, irreversibility, and consent dimensions require new instruments, not just extension of existing GMO frameworks.

Common Confusions

Trap · Gene drive is the same as GMO
Correct: All gene-drive organisms are GMOs, but most GMOs are not gene-drive. Gene drives specifically bias inheritance beyond 50%; conventional GM crops follow Mendelian inheritance.
Trap · CRISPR Nobel year and awardees
Correct: 2020 Chemistry Nobel — Emmanuelle Charpentier and Jennifer Doudna. Not Watson-Crick (DNA structure) or any other pair.
Trap · Target species in African studies
Correct: Anopheles gambiae is the Africa target; Aedes aegypti is the dengue/yellow-fever vector; Anopheles stephensi is more relevant to urban Asian malaria.

Flashcard

Q · Gene drive — core mechanism and what makes it different from Mendelian inheritance?tap to reveal

A · A gene drive biases inheritance so the modified gene passes to over 90% of offspring (vs 50% under standard Mendelian inheritance), allowing a trait to spread through a wild population in a few generations. Used in Tanzania field study against malaria via CRISPR-Cas9 edits in Anopheles gambiae.

Interlinkages

Cartagena Protocol on Biosafety, 2000 (under Convention on Biological Diversity)WHO Global Malaria ProgrammeBiological Diversity Act, 2002 (India)Genetic Engineering Appraisal Committee (GEAC), IndiaNagoya Protocol on Access and Benefit-sharing, 2010

Prerequisites · concepts to brush up first

Basic Mendelian genetics and inheritance
What GMOs and genetic engineering mean
Malaria transmission cycle

Topics

science-tech/biotech/crisprscience-tech/health/public-healthinternational/multilateral/un

Back to 21 Apr 2026 bundle

Why in News

At a Glance

Static GK

Exam Angles

Common Confusions

Flashcard

Suggested Reading

Interlinkages